Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-09-12

Clinical Trial Update: A Study in Migraine Prevention [Phase 2]

View source ↗

Summary

Phase 2 clinical trial in migraine prevention was terminated; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Eli Lilly and Company | Conditions: Migraine Headache | Phase 2 | Status: TERMINATED | Results posted: 2018-09-12